Relationship of blood monocytes with chronic lymphocytic leukemia aggressiveness and outcomes: a multi‐institutional study
Daphne R. Friedman(Duke Medical Center), Ryan A. Wilcox(University of Michigan), Kouros Owzar(Duke University), Tait D. Shanafelt(Mayo Clinic), Susan L. Slager(Mayo Clinic), Wei Ding(Mayo Clinic), J. Brice Weinberg(United States Department of Veterans Affairs), Curtis A. Hanson(Toyota Motor Corporation (Switzerland)), Neil E. Kay(Mayo Clinic), Kari G. Chaffee(Mayo Clinic in Florida), Alexander B. Sibley(Duke University)
Cited by 28
Related Papers
Executive Leadership and Physician Well-being
|Mayo Clinic Proceedings|2016|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial
|The Lancet|2009|1.4k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k